Patient Guide: A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 71 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04951219
Status: ACTIVE_NOT_RECRUITING
Condition: Non-Alcoholic Fatty Liver Disease
Phase: PHASE3

Find a Study Location Near You

This study is available at 71 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Chandler, Arizona
  • Chandler, Arizona
  • • And 68 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily